We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03900429
Brief Title: A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis (MAESTRO-NASH)

First Submitted : March 26, 2019
First Submitted that Met QC Criteria : March 30, 2019
First Posted : April 3, 2019

Last Update Submitted that Met QC Criteria : December 2, 2022
Last Update Posted : December 6, 2022